Though we do not discuss medications in detail, we highlight recent advances.

Then we highlight recent studies illustrating the hot-spot effect for drug-release.

In this review, we highlight recent progress in our understanding of these processes.

In the present paper, we review historical aspects of the area and highlight recent key developments.

Here, we highlight recent findings regarding the regulation of protein targeting during invadopodia formation and function.

In this Perspective, we highlight recent developments in targeting mitochondrial metabolism for the treatment of cancer.

In this review, we highlight recent advances in neurotrophin research and discuss their relevance to neurologic disease.

We also highlight recent notable studies and novel approaches to provide an overview of advanced EHR-based phenotyping.

In this review, we highlight recent progress of the design of drug nanocarriers using a zwitterionic strategy.

This review will highlight recent advances in the understanding of the role of TSLP in these inflammatory diseases.

We also highlight recent developments of these three technologies and how these developments are applicable to ageing research.

This review will highlight recent findings that link inflammasome signaling to the progression of autoinflammatory and autoimmune diseases.

Here, we highlight recent progress in the development of bromodomain inhibitors, and their potential applications in drug discovery.

Finally, we highlight recent technological developments that permit measurements at the single-cell level, and discuss directions for future research.

Herein, we highlight recent advances and discuss potential future directions toward understanding the role of inflammasomes during virus infection.

Objectives: In this review, we highlight recent findings discussing the potential mechanisms by which AAPs may contribute to hypertriglyceridemia.